What does HEALTH SCIENCE & NUTRITION do?

HEALTH SCIENCE & NUTRITION is a wholesaler in Aalter. Public Limited, started on 8 October 2013, 2 establishments.

What is the address of HEALTH SCIENCE & NUTRITION?

The registered office of HEALTH SCIENCE & NUTRITION is located at Langendamdreef 10 box A, 9880 Aalter.

Is HEALTH SCIENCE & NUTRITION still active?

Yes. According to the CBE (30 October 2026) HEALTH SCIENCE & NUTRITION is active, legal situation “Normale toestand”, started on 8 October 2013.

Is HEALTH SCIENCE & NUTRITION registered on Peppol?

Yes, HEALTH SCIENCE & NUTRITION is registered on the Peppol network with ID 0208:0540937029.

What is the enterprise number of HEALTH SCIENCE & NUTRITION?

The enterprise number of HEALTH SCIENCE & NUTRITION is BE0540937029.

When was HEALTH SCIENCE & NUTRITION founded?

HEALTH SCIENCE & NUTRITION was founded on 8 October 2013.

Who are the directors of HEALTH SCIENCE & NUTRITION?

According to the 2025 annual accounts, the directors of HEALTH SCIENCE & NUTRITION are: BIBULUS VOF VOF, Peter Wildemeersch, Elisabeth HOUBEN, V. FVA INVEST 3 Comm..

Is HEALTH SCIENCE & NUTRITION a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 October 2013; 5 annual accounts filed, latest fiscal year 2025; 4 directors known from the annual account; 2 establishments in the CBE.

How much profit did HEALTH SCIENCE & NUTRITION make in 2025?

HEALTH SCIENCE & NUTRITION posted a profit after taxes of € 878 in financial year 2025.

What is the revenue of HEALTH SCIENCE & NUTRITION?

As a small company, HEALTH SCIENCE & NUTRITION is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 264,300.

How much does an employee at HEALTH SCIENCE & NUTRITION earn?

The average wage cost per full-time employee at HEALTH SCIENCE & NUTRITION was € 60,900 in 2023: staff costs of € 201,115 for 3.3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

Does HEALTH SCIENCE & NUTRITION have a website?

Yes, HEALTH SCIENCE & NUTRITION has a website at health-science.be.

HEALTH SCIENCE & NUTRITION (Public Limited) - Aalter

Dossier HEALTH SCIENCE & NUTRITION, printed on 30 October 2026 from databakkes.be/en/0540937029/health-science-nutrition. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.
Tight liquidity NBB

Cash and receivables cover 60 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

HEALTH SCIENCE & NUTRITION from Aalter, company number BE0540937029, closed financial year 2025 with a result of € 878 after tax. For that financial year HEALTH SCIENCE & NUTRITION recorded a gross margin of € 264,300 and equity of € -27,960. Compared with financial year 2024, the result moved from € -13,847 to € 878. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.

What it is worth Caution

€ -27,960

▲ € 878 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 878

▲ still € 13,847 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 41,028

▲ 17% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € -89,460.

People and assets in 2025

Wage cost

€ 221,685

▼ 4% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,423

▲ 56% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 146,836

▲ 14% vs 2024

€ 39,086 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 72,198

▼ 51% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 27,053

▼ 4% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 231,136 Gross margin 2022: € 231,136 First fiscal year in the series	€ 261,143 Gross margin 2023: € 261,143 ▲ 13% vs 2022 (€ 231,136) Favourable step	€ 266,507 Gross margin 2024: € 266,507 ▲ 2% vs 2023 (€ 261,143) Favourable step	€ 264,300 Gross margin 2025: € 264,300 ▼ 1% vs 2024 (€ 266,507) Unfavourable step	▼ 1%
Profit after taxes	€ 29,016 Profit after taxes 2022: € 29,016 First fiscal year in the series	€ 8,786 Profit after taxes 2023: € 8,786 ▼ 70% vs 2022 (€ 29,016) Unfavourable step	€ -13,847 Profit after taxes 2024: € -13,847 ▼ € 22,633 vs 2023 (€ 8,786) Unfavourable step	€ 878 Profit after taxes 2025: € 878 ▲ € 14,725 vs 2024 (€ -13,847) Favourable step	▲ € 14,725
Equity	€ -23,736 Equity 2022: € -23,736 First fiscal year in the series	€ -14,991 Equity 2023: € -14,991 ▲ € 8,745 vs 2022 (€ -23,736) Favourable step	€ -28,838 Equity 2024: € -28,838 ▼ € 13,847 vs 2023 (€ -14,991) Unfavourable step	€ -27,960 Equity 2025: € -27,960 ▲ € 878 vs 2024 (€ -28,838) Favourable step	▲ € 878
Total debts	€ 339,330 Total debts 2022: € 339,330 First fiscal year in the series	€ 334,691 Total debts 2023: € 334,691 ▼ 1% vs 2022 (€ 339,330) Favourable step	€ 382,214 Total debts 2024: € 382,214 ▲ 14% vs 2023 (€ 334,691) Unfavourable step	€ 305,380 Total debts 2025: € 305,380 ▼ 20% vs 2024 (€ 382,214) Favourable step	▼ 20%
Cash	€ 47,950 Cash 2022: € 47,950 First fiscal year in the series	€ 10,170 Cash 2023: € 10,170 ▼ 79% vs 2022 (€ 47,950) Unfavourable step	€ 35,110 Cash 2024: € 35,110 ▲ 245% vs 2023 (€ 10,170) Favourable step	€ 41,028 Cash 2025: € 41,028 ▲ 17% vs 2024 (€ 35,110) Favourable step	▲ 17%
Retained profit	€ -85,236 Retained profit 2022: € -85,236 First fiscal year in the series	€ -76,491 Retained profit 2023: € -76,491 ▲ € 8,745 vs 2022 (€ -85,236) Favourable step	€ -90,338 Retained profit 2024: € -90,338 ▼ € 13,847 vs 2023 (€ -76,491) Unfavourable step	€ -89,460 Retained profit 2025: € -89,460 ▲ € 878 vs 2024 (€ -90,338) Favourable step	▲ € 878
Bank debt	€ 108,353 Bank debt 2022: € 108,353 First fiscal year in the series	€ 111,972 Bank debt 2023: € 111,972 ▲ 3% vs 2022 (€ 108,353) Unfavourable step	€ 129,224 Bank debt 2024: € 129,224 ▲ 15% vs 2023 (€ 111,972) Unfavourable step	€ 146,836 Bank debt 2025: € 146,836 ▲ 14% vs 2024 (€ 129,224) Unfavourable step	▲ 14%
Balance sheet total	€ 315,593 Balance sheet total 2022: € 315,593 First fiscal year in the series	€ 319,699 Balance sheet total 2023: € 319,699 ▲ 1% vs 2022 (€ 315,593) Unchanged	€ 353,375 Balance sheet total 2024: € 353,375 ▲ 11% vs 2023 (€ 319,699) Unchanged	€ 277,420 Balance sheet total 2025: € 277,420 ▼ 21% vs 2024 (€ 353,375) Unchanged	▼ 21%
Employees (FTE)	-	3.3 Employees (FTE) 2023: 3.3 First fiscal year in the series	-	-

Key figures of HEALTH SCIENCE & NUTRITION, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to HEALTH SCIENCE & NUTRITION?

What happened at HEALTH SCIENCE & NUTRITION in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 Peter Wildemeersch stepped down as director. NBB
2029 Elisabeth HOUBEN stepped down as director. NBB
2029 V. FVA INVEST 3 Comm. stepped down as director. NBB
Sep 30, 2026 New annual accounts for financial year 2025: profit of € 878. filed late Source: NBB ↗
2024 BIBULUS VOF VOF became a director. NBB
2024 Peter Wildemeersch became a director. NBB
2024 Elisabeth HOUBEN became a director. NBB
2024 V. FVA INVEST 3 Comm. became a director. NBB

In short

From € 29,016 profit in 2022 to € 878 profit in 2025.

Paid € 58,644 in corporate taxes since 2022.

Best year ever: 2022, with € 29,016 profit.

On average € 79,100 of value added per employee in 2023.

Original PDFs at the National Bank ↗

Management

BIBULUS VOF VOF

HEALTH SCIENCE & NUTRITION

TICO INVEST RETAIL

CAPRA

TICO INVEST WAREHOUSING

Behind HEALTH SCIENCE & NUTRITION is BIBULUS VOF VOF. BIBULUS VOF VOF is also behind TICO INVEST RETAIL, CAPRA, TICO INVEST WAREHOUSING and TICO INVEST.

Directors

According to the 2025 annual accounts

BIBULUS VOF VOF

Director · represented by Boeckx Tim

Also active at: TICO INVEST RETAIL, CAPRA, TICO INVEST WAREHOUSING, TICO INVEST

since 2024

Peter Wildemeersch

Director

since 2024 · until 2029

Elisabeth HOUBEN

Director

since 2024 · until 2029

V. FVA INVEST 3 Comm.

Director

since 2024 · until 2029

Establishments

Establishment units

Physical locations of this company

Registered office

Langendamdreef 10 box A

9880 Aalter

2.281.837.797

Langendamdreef 10 box A000

9880 Aalter

Active since 20 November 2018

2.281.837.896

Abdij Vlierbeek 7 box C

3010 Leuven

Active since 20 November 2018

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS health-science.be

Canonical: https://www.health-science.be/

About

Technologies

AOSAmazon CloudFrontCloudflare CDNGoogle AnalyticsGoogle FontsMailchimpPHPShopifySlickjQuerylazysizesreCAPTCHA

Hosting & Email

Email provider

Self-hosted

Hosting

CLOUDFLARENET - Cloudflare, Inc., US

Website info

HTTPS Ja

Languages EN, ES, FR, NL

Features

Webshop Blog Client portal Contact page

Security

✓ HTTPS

✓ SPF

✓ DMARC

Details

Company number

0540.937.029

VAT number

BE 0540.937.029

Registered office

Langendamdreef 10 bus A, 9880 Aalter

Names & denominations

HEALTH SCIENCE & NUTRITION

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

8 October 2013

Peppol

Active · Active since 21 Oct 2026

Contact

health-science.be

Activities · NACE

Groothandel in andere voedingsmiddelen, neg

Handelsbemiddeling in de groothandel in voedings- en genotmiddelen

View on CBE Public ↗ Annual accounts (NBB) ↗

HEALTH SCIENCE & NUTRITION

Warning lights

Financials

What happened to HEALTH SCIENCE & NUTRITION?

Management

Directors

Establishments

Establishment units

Website

Technologies

Hosting & Email

Website info

Features

Security

Details

Frequently asked questions